BioCentury
ARTICLE | Clinical News

Vibativ telavancin regulatory update

March 24, 2014 7:00 AM UTC

The European Commission lifted a suspension on an MAA for Theravance's Vibativ telavancin to treat hospital-acquired (nosocomial) pneumonia known or suspected to be caused by methicillin-resistant Sta...